Table of Contents
Advances in Hepatology
Volume 2014 (2014), Article ID 632320, 7 pages
http://dx.doi.org/10.1155/2014/632320
Review Article

IgG4 Related Sclerosing Cholangitis

Department of Gastroenterology, University College London Hospital, 250 Euston Road, London NW1 2PG, UK

Received 7 August 2014; Revised 13 October 2014; Accepted 15 October 2014; Published 10 November 2014

Academic Editor: Sharon DeMorrow

Copyright © 2014 D. Joshi and G. J. M. Webster. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Kamisawa, N. Egawa, and H. Nakajima, “Autoimmune pancreatitis is a systemic autoimmune disease,” The American Journal of Gastroenterology, vol. 98, no. 12, pp. 2811–2812, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. T. Kamisawa, N. Funata, Y. Hayashi et al., “A new clinicopathological entity of IgG4-related autoimmune disease,” Journal of Gastroenterology, vol. 38, no. 10, pp. 982–984, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. R. P. Sah, S. T. Chari, R. Pannala et al., “Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis,” Gastroenterology, vol. 139, no. 1, pp. 140–148, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Okazaki, K. Uchida, M. Koyabu, H. Miyoshi, and M. Takaoka, “Recent advances in the concept and diagnosis of autoimmune pancreatitis and IgG4-related disease,” Journal of Gastroenterology, vol. 46, no. 3, pp. 277–288, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Dahlgren, A. Khosroshahi, G. P. Nielsen, V. Deshpande, and J. H. Stone, “Riedel's thyroiditis and multifocal fibrosclerosis are part of the IgG4-related systemic disease spectrum,” Arthritis Care and Research, vol. 62, no. 9, pp. 1312–1318, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Saeki, A. Saito, T. Hiura et al., “Lymphoplasmacytic infiltration of multiple organs with immunoreactivity for IgG4: IgG4-related systemic disease,” Internal Medicine, vol. 45, no. 3, pp. 163–167, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Kamisawa, K. Takuma, N. Egawa, K. Tsuruta, and T. Sasaki, “Autoimmune pancreatitis and IgG4-related sclerosing disease,” Nature Reviews Gastroenterology & Hepatology, vol. 7, pp. 401–409, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. J. H. Stone, A. Khosroshahi, A. Hilgenberg, A. Spooner, E. M. Isselbacher, and J. R. Stone, “IgG4-related systemic disease and lymphoplasmacytic aortitis,” Arthritis & Rheumatism, vol. 60, no. 10, pp. 3139–3145, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Hamano, N. Arakura, T. Muraki, Y. Ozaki, K. Kiyosawa, and S. Kawa, “Prevalence and distribution of extrapancreatic lesions complicating autoimmune pancreatitis,” Journal of Gastroenterology, vol. 41, no. 12, pp. 1197–1205, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Zen and Y. Nakanuma, “IgG4-related disease: a cross-sectional study of 114 cases,” The American Journal of Surgical Pathology, vol. 34, no. 12, pp. 1812–1819, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Kanno, I. Nishimori, A. Masamune et al., “Nationwide epidemiological survey of autoimmune pancreatitis in Japan,” Pancreas, vol. 41, no. 6, pp. 835–839, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. W. Cheuk and J. K. C. Chan, “IgG4-related sclerosing disease: a critical appraisal of an evolving clinicopathologic entity,” Advances in Anatomic Pathology, vol. 17, no. 5, pp. 303–332, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. I. M. Stromnes, L. M. Cerretti, D. Liggitt, R. A. Harris, and J. M. Goverman, “Differential regulation of central nervous system autoimmunity by TH1 and TH17 cells,” Nature Medicine, vol. 14, no. 3, pp. 337–342, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Zen, T. Fujii, K. Harada et al., “Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis,” Hepatology, vol. 45, no. 6, pp. 1538–1546, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Kountouras, C. Zavos, and D. Chatzopoulos, “A concept on the role of Helicobacter pylori infection in autoimmune pancreatitis,” Journal of Cellular and Molecular Medicine, vol. 9, no. 1, pp. 196–207, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. R. C. Aalberse, S. O. Stapel, J. Schuurman, and T. Rispens, “Immunoglobulin G4: an odd antibody,” Clinical and Experimental Allergy, vol. 39, no. 4, pp. 469–477, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. V. Deshpande, S. Chicano, D. Finkelberg et al., “Autoimmune pancreatitis: a systemic immune complex mediated disease,” The American Journal of Surgical Pathology, vol. 30, no. 12, pp. 1537–1545, 2006. View at Google Scholar
  18. F. D. Mendes, R. Jorgensen, J. Keach et al., “Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis,” The American Journal of Gastroenterology, vol. 101, no. 9, pp. 2070–2075, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Shimosegawa, S. T. Chari, L. Frulloni et al., “International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the international association of pancreatology,” Pancreas, vol. 40, no. 3, pp. 352–358, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. S. T. Chari, T. C. Smyrk, M. J. Levy et al., “Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience,” Clinical Gastroenterology and Hepatology, vol. 4, no. 8, pp. 1010–1016, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. V. Deshpande, Y. Zen, J. K. Chan et al., “Consensus statement on the pathology of IgG4-related disease,” Modern Pathology, vol. 25, no. 9, pp. 1181–1192, 2012. View at Publisher · View at Google Scholar
  22. A. Khosroshahi and J. H. Stone, “Treatment approaches to IgG4-related systemic disease,” Current Opinion in Rheumatology, vol. 23, no. 1, pp. 67–71, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Khosroshahi, M. N. Carruthers, V. Deshpande, S. Unizony, D. B. Bloch, and J. H. Stone, “Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients,” Medicine, vol. 91, no. 1, pp. 57–66, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Khosroshahi, D. B. Bloch, V. Deshpande, and J. H. Stone, “Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease,” Arthritis & Rheumatism, vol. 62, no. 6, pp. 1755–1762, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Shiokawa, Y. Kodama, K. Yoshimura et al., “Risk of cancer in patients with autoimmune pancreatitis,” The American Journal of Gastroenterology, vol. 108, no. 4, pp. 610–617, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Ghazale, S. T. Chari, L. Zhang et al., “Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy,” Gastroenterology, vol. 134, no. 3, pp. 706–715, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Hirano, Y. Shiratori, Y. Komatsu et al., “Involvement of the biliary system in autoimmune pancreatitis: a follow-up study,” Clinical Gastroenterology and Hepatology, vol. 1, no. 6, pp. 453–464, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. N. I. Church, S. P. Pereira, D. Churchill, S. Cairns, A. R. W. Hatfield, and G. J. M. Webster, “Chronic pancreatitis: diagnosis and management of complications,” Gut, vol. 56, no. 9, pp. 1189–1190, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. T. Nishino, F. Toki, H. Oyama et al., “Biliary tract involvement in autoimmune pancreatitis,” Pancreas, vol. 30, no. 1, pp. 76–82, 2005. View at Google Scholar · View at Scopus
  30. D. H. Yang, K. W. Kim, T. K. Kim et al., “Autoimmune pancreatitis: radiologic findings in 20 patients,” Abdominal Imaging, vol. 31, no. 1, pp. 94–102, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. D. V. Sahani, S. P. Kalva, J. Farrell et al., “Autoimmune pancreatitis: imaging features,” Radiology, vol. 233, no. 2, pp. 345–352, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Nakazawa, I. Naitoh, K. Hayashi, K. Miyabe, S. Simizu, and T. Joh, “Diagnosis of IgG4-related sclerosing cholangitis,” World Journal of Gastroenterology, vol. 19, no. 43, pp. 7661–7670, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Sugumar, M. J. Levy, T. Kamisawa et al., “Endoscopic retrograde pancreatography criteria to diagnose autoimmune pancreatitis: an international multicentre study,” Gut, vol. 60, no. 5, pp. 666–670, 2011. View at Publisher · View at Google Scholar
  34. N. Hyodo and T. Hyodo, “Ultrasonographic evaluation in patients with autoimmune-related pancreatitis,” Journal of Gastroenterology, vol. 38, no. 12, pp. 1155–1161, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. N. S. Sandanayake, N. I. Church, M. H. Chapman et al., “Presentation and management of post-treatment relapse in autoimmune pancreatitis/immunoglobulin G4-associated cholangitis,” Clinical Gastroenterology and Hepatology, vol. 7, no. 10, pp. 1089–1096, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. S.-H. Moon, M.-H. Kim, D. H. Park et al., “IgG4 immunostaining of duodenal papillary biopsy specimens may be useful for supporting a diagnosis of autoimmune pancreatitis,” Gastrointestinal Endoscopy, vol. 71, no. 6, pp. 960–966, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. N. Okano, Y. Igarashi, Y. Kishimoto, K. Ito, and D. Sasai, “Case of immunoglobulin G4-related cholangitis accompanying autoimmune pancreatitis: diagnosis by peroral cholangioscopy and treatment by endoscopic biliary stenting,” Digestive Endoscopy, vol. 24, no. 1, pp. 62–66, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. T. Itoi, T. Kamisawa, Y. Igarashi et al., “The role of peroral video cholangioscopy in patients with IgG4-related sclerosing cholangitis,” Journal of Gastroenterology, vol. 48, no. 4, pp. 504–514, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. E. Kalaitzakis, M. Levy, T. Kamisawa et al., “Endoscopic retrograde cholangiography does not reliably distinguish IgG4-associated cholangitis from primary sclerosing cholangitis or cholangiocarcinoma,” Clinical Gastroenterology and Hepatology, vol. 9, no. 9, pp. 800.e2–803.e2, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. T. Kamisawa, T. Shimosegawa, K. Okazaki et al., “Standard steroid treatment for autoimmune pancreatitis,” Gut, vol. 58, no. 11, pp. 1504–1507, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. E. Björnsson, S. Chari, M. Silveira et al., “Primary sclerosing cholangitis associated with elevated immunoglobulinG4: clinical characteristics and response to therapy,” American Journal of Therapeutics, vol. 18, no. 3, pp. 198–205, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. P. A. Hart, M. D. Topazian, T. E. Witzig et al., “Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience,” Gut, vol. 62, no. 11, pp. 1607–1615, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. D. Lytras, E. Kalaitzakis, G. J. M. Webster et al., “Cholangiocarcinoma or IgG4-associated cholangitis: how feasible it is to avoid unnecessary surgical interventions?” Annals of Surgery, vol. 256, no. 6, pp. 1059–1067, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. N. I. Church, S. P. Pereira, M. G. Deheragoda et al., “Autoimmune pancreatitis: clinical and radiological features and objective response to steroid therapy in a UK series,” The American Journal of Gastroenterology, vol. 102, no. 11, pp. 2417–2425, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. M. T. Huggett, E. L. Culver, M. Kumar et al., “Type 1 autoimmune pancreatitis and IgG4-related sclerosing cholangitis is associated with extrapancreatic organ failure, malignancy, and mortality in a prospective UK cohort,” The American Journal of Gastroenterology, vol. 109, no. 10, pp. 1675–1683, 2014. View at Publisher · View at Google Scholar
  46. “Rituximab in IgG4-related disease: a Phase 1-2 Trial,” http://clinicaltrials.gov/show/NCT01584388.
  47. “Glucocorticoids in patients with IgG4-RD,” http://clinicaltrials.gov/show/NCT01758393.